Search Results

Cerebral Flow Diverters and Disruptors in 2021: Where Do We Stand?

Key advancements, new devices, landmark trials, treatment strategies by aneurysm type, location, and clinical content, and future directions.

With Bree Chancellor, MD, MBA, and Peter K. Nelson, MD

Optimizing Stroke and Cerebral Aneurysm Care

By Dorothea Altschul, MD, FAHA

What Is Your Preferred EVAR Device and Why?

By Michael J. Singh, MD, FACS, RPVI; Sharif Ellozy, MD; Mark K. Eskandari, MD, FACS; Ross Milner, MD; Ronald M. Fairman, MD; and Peter R. Nelson, MD, MS

Myocardial Infarction After CAS and CEA: Why Does It Matter?

Clinical or subclinical MI predicts mortality after carotid intervention and should be included in the primary endpoint composite of carotid trials.

By Peter Kan, MD, MPH; Travis M. Dumont, MD; Adib A. Anla, MD; Adnan H. Siddiqui, MD, PhD; Elad I. Levy, MD; and L. Nelson Hopkins, MD

When Is Surgery Still the Best Option?

Given the variety of endovascular treatment modalities for lower-leg interventions, when should physicians consider surgical treatment in their patient management?

By Panagiotis Kougias, MD; Wei Zhou, MD; Alan B. Lumsden, MD; and Peter H. Lin, MD

Surveying the CAS Landscape

By Sumaira Macdonald, MBChB (Comm.), FRCP, FRCR, PhD, and William A. Gray, MD

The State of CAS

By William A. Gray, MD, and Sumaira Macdonald, MBChB, FRCP, FRCR, PhD